Dr. MarkAlain Déry, MPH on Malaria Monoclonal Antibodies

By Lou Portero - Last Updated: December 14, 2022

Dr. MarkAlain Déry, MPH discusses the burden of malaria in Sub-Saharan Africa and combating it using Monoclonal Antibodies.
Connect with Dr. Déry:
@TheDrDery
NoiseFilterShow.com

Home Laundering of Healthcare Uniforms: Potential Risk for Infection Transmission and Antimicrobial Resistance

Lou PorteroPublic Health | May 18, 2025

New research reveals domestic washing machines may fail to disinfect healthcare textiles properly.

Shingles Vaccine May Reduce Risk of Dementia

Rebecca AraujoAlzheimer's & Dementia | April 3, 2025

Shingles vaccination was associated with a 20% reduction in risk of dementia in the 7 years after inoculation.

Better Interpersonal Care Boosts HIV Patient Engagement, Study Finds

Lou PorteroHIV | March 30, 2025

Missed clinic visits decreased substantially, and overall retention in care improved markedly.

Measles Makes an Unwelcome Return

Lou PorteroInfectious Diseases | March 17, 2025

Reports highlight that measles remains highly contagious, capable of infecting nine out of ten susceptible exposed

H5N1 Bird Flu: Concerns, Data, and Expert Insights

Tamara ThomasInfectious Diseases | February 22, 2025

So far, no evidence of sustained person-to-person transmission exists.

Dr. MarkAlain Déry, MPH on Malaria Monoclonal Antibodies

Related Posts